Guerbet Logo

Guerbet

Offers medical imaging solutions, from contrast agents to AI, for healthcare professionals.

GBT | PA

Overview

Corporate Details

ISIN(s):
FR0000032526 (+3 more)
LEI:
969500WV1U1WQ059L135
Country:
France
Address:
15 RUE DES VANESSES, 93420 VILLEPINTE
Sector:
Manufacturing
Industry:
Manufacture of medical and dental instruments and supplies

Description

Guerbet is a global leader in medical imaging, specializing in diagnostic and interventional imaging solutions for healthcare professionals. Since its establishment in 1926, the company has developed and commercialized a comprehensive portfolio that includes contrast agents, medical devices, delivery systems, and digital and AI-powered solutions. Guerbet's products are utilized to improve the diagnosis and treatment of major disease areas such as cancer, as well as cardiovascular, inflammatory, and neurodegenerative diseases. The company focuses on providing innovative and safe solutions to enhance patient care and support radiology professionals worldwide.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-24 17:45
Earnings Release
Guerbet : H1 2025 results : H1 revenue: €387.8 million, down 5.4% at CER and on…
English 524.6 KB
2025-09-24 17:45
Earnings Release
Guerbet : Résultats semestriels 2025 : Chiffre d’affaires du 1er semestre : 387…
French 496.3 KB
2025-09-22 17:45
Board/Management Information
Guerbet : Evolution de la Direction Générale
French 134.4 KB
2025-09-22 17:45
Board/Management Information
Guerbet : Change in General Management
English 113.8 KB
2025-09-18 17:45
Declaration of Voting Results & Voting Rights Announcements
GUERBET : Nombre d'actions et de droits de vote composant le capital de la soci…
French 159.1 KB
2025-09-15 17:50
Earnings Release
Guerbet : Ajustement des objectifs financiers annuels 2025
French 209.3 KB
2025-09-15 17:50
Earnings Release
Guerbet : Adjustment of 2025 full-year financial targets
English 186.1 KB
2025-08-13 17:45
Declaration of Voting Results & Voting Rights Announcements
GUERBET : Nombre d'actions et de droits de vote composant le capital de la soci…
French 158.8 KB
2025-07-25 17:45
Regulatory News Service
GUERBET : Descriptif du programme de rachat d’actions autorisé par l’Assemblée …
French 170.5 KB
2025-07-09 17:45
Regulatory News Service
GUERBET : Bilan semestriel du contrat de liquidité
French 116.1 KB
2025-07-08 17:30
Declaration of Voting Results & Voting Rights Announcements
GUERBET : Nombre d'actions et de droits de vote composant le capital de la soci…
French 99.1 KB
2025-06-18 17:30
Declaration of Voting Results & Voting Rights Announcements
GUERBET : Nombre d'actions et de droits de vote composant le capital de la soci…
French 98.5 KB
2025-05-26 08:42
Post-Annual General Meeting Information
Guerbet : Evolution de la composition du Conseil d'administration de Guerbet.
French 250.9 KB
2025-05-26 08:42
Board/Management Information
Guerbet : Changes in the composition of the Guerbet board of directors.
English 164.7 KB
2025-05-16 17:30
Declaration of Voting Results & Voting Rights Announcements
GUERBET : Nombre d'actions et de droits de vote composant le capital de la soci…
French 96.3 KB

Automate Your Workflow. Get a real-time feed of all Guerbet filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Guerbet via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2024-08-19 N/A Other Buy 142 4,989.31 EUR
2024-08-15 N/A Other Buy 195 6,678.75 EUR
2024-08-12 N/A Other Buy 1,000 34,350.00 EUR
2024-04-18 N/A Other Sell 550 17,699.00 EUR
2023-11-30 N/A Other Sell 700 12,684.00 EUR
2023-11-03 N/A Other Buy 1 17.92 EUR
2023-10-30 N/A Other Buy 1,000 17,000.00 EUR
2023-10-25 N/A Other Buy 1,000 16,800.00 EUR
2023-10-24 N/A Other Buy 1,000 16,460.90 EUR
2023-05-04 N/A Other Buy 300 4,938.00 EUR

Peer Companies

Company Country Ticker View
ProstaLund AB Logo
Develops minimally invasive heat treatments and devices for BPH for global healthcare providers.
Sweden PLUN
Prostatype Genomics AB Logo
Provides a genetic test to assess prostate cancer aggressiveness and guide treatment choices.
Sweden PROGEN
Qiagen N.V. Logo
Provides 'Sample to Insight' solutions for molecular analysis in research and clinical healthcare.
Netherlands QIA
QLife Holding AB Logo
Develops an at-home IVD platform for biomarker and virus testing from blood samples.
Sweden QLIFE
IVD specialist in rapid antimicrobial susceptibility testing for critical infections like sepsis.
South Korea 317690
Raphas Co., Ltd. Logo
Develops dissolving microneedle patches for cosmetic, medical, and pharmaceutical applications.
South Korea 214260
Redsense Medical AB Logo
Develops FDA/CE-marked blood loss alarms for hemodialysis using fiber optic tech for EU/US markets.
Sweden REDS
Revenio Group Oyj Logo
Develops ophthalmic devices and software for early detection of significant eye diseases.
Finland REG1V
ROKIT HEALTHCARE Inc. Logo
Uses 3D bioprinting and AI for autologous organ regeneration to treat chronic conditions.
South Korea 376900
RootLoc Co., Ltd. Logo
Develops and sells orthopedic solutions like artificial joints and spinal implants globally.
South Korea 253610

Talk to a Data Expert

Have a question? We'll get back to you promptly.